Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-220688
Filing Date
2026-05-13
Accepted
2026-05-13 08:30:23
Documents
14
Period of Report
2026-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d137084ddef14a.htm   iXBRL DEF 14A 407206
3 GRAPHIC g137084dsp012.jpg GRAPHIC 258818
4 GRAPHIC g137084dsp013.jpg GRAPHIC 166384
5 GRAPHIC g137084g68p04.jpg GRAPHIC 63831
  Complete submission text file 0001193125-26-220688.txt   1981197

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coya-20251231.xsd EX-101.SCH 6255
17 EXTRACTED XBRL INSTANCE DOCUMENT d137084ddef14a_htm.xml XML 5219
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41583 | Film No.: 26971056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)